Clinical trials
Phase 1 Multiple Myeloma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 9 |
| Active, not recruiting | 5 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| AbbVie | 5 |
| Celgene | 4 |
| Amgen | 2 |
| Janssen Research & Development, LLC | 2 |
| 4SC AG | 1 |
| Anaveon AG | 1 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 32 |
| Recurrence | 7 |
| Neoplasms | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma | 3 |
| Neoplasms, Plasma Cell | 3 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 2 |
| Lymphoma, B-Cell | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.